Clinical Trials Search at Vanderbilt-Ingram Cancer Center
Phase 2 Study of Glesatinib, Sitravatinib or Mocetinostat in Combination With Nivolumab in Non-Small Cell Lung Cancer
Multiple Cancer Types
The study will evaluate the clinical activity of nivolumab in combination with 3 separate investigational agents, glesatinib, sitravatinib, or mocetinostat.
Lung,
Non Small Cell
II
Horn, Leora
NCT02954991
VICCTHO16139
